Protalix BioTherapeutics
PLX
#8576
Rank
NZ$0.20 B
Marketcap
$2.83
Share price
-1.78%
Change (1 day)
22.94%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2023 (TTM): $0.17

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is $0.17. In 2022 the company made an earnings per share (EPS) of -$0.51 an increase over its 2021 EPS that were of -$1.06.

EPS history for Protalix BioTherapeutics from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.17-132.49%
2022-$0.51-51.61%
2021-$1.06342.86%
2020-$0.24-88.71%
2019-$2.11-34.74%
2018-$3.24-70.92%
2017-$11.142153.35%
2016-$0.49-146.77%
2015$1.06-287.88%
2014-$0.5610%
2013-$0.51130.77%
2012-$0.22-56.67%
2011-$0.51-46.43%
2010-$0.9536.59%
2009-$0.7032.26%
2008-$0.53-93.4%
2007-$8.011298.53%
2006-$0.57-96.59%
2005-$16.8119.32%
2004-$14.081552.65%
2003-$0.85-0%
2002-$0.85-50%
2001-$1.70233.33%
2000-$0.51-84.21%
1999-$3.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.09-740.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.34 1,860.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.17 1,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.41-2,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel